Offer - Urjas Oil for just ₹ 1 X
Regat (Kopran Ltd) is a prescription drug, available for use as Tablet. It is typically used for the treatment of Conjunctivitis. Regat (Kopran Ltd) also has some secondary and off-label uses. These are listed below.
The correct dosage of Regat (Kopran Ltd) depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Regat (Kopran Ltd) also has some side effects, the most common being Nausea or vomiting, Diarrhoea, Dizziness. Apart from the aforementioned side effects, Regat (Kopran Ltd) can also lead to other problems, which have been listed below. These side effects of Regat (Kopran Ltd) are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Regat (Kopran Ltd)'s effect is Moderate during pregnancy and Severe for lactating mothers. Further, the section on Regat (Kopran Ltd) related warnings talks about Regat (Kopran Ltd)'s effects on the liver, heart and kidney.
Regat (Kopran Ltd) is contraindicated in people with pre-existing medical conditions like Myasthenia Gravis (MG), Brain and Nervous System, Tendon Injury (Tendinopathy) as it can result in adverse effects. The section on Regat (Kopran Ltd) contraindications lists all such conditions.
Additionally, Regat (Kopran Ltd) may also adversely react with other medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Regat (Kopran Ltd) is safe while driving, and is is addictive in nature.
Regat (Kopran Ltd) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Regat (Kopran Ltd) safe for pregnant women?
Regat (Kopran Ltd) may have some side effects during pregnancy. Pregnant women should discontinue the use of Regat (Kopran Ltd), and talk to their doctor, if they notice any discomfort.
Is the use of Regat (Kopran Ltd) safe during breastfeeding?
Regat (Kopran Ltd) should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Regat (Kopran Ltd) on the Kidneys?
Regat (Kopran Ltd) is not harmful for kidneys.
What is the effect of Regat (Kopran Ltd) on the Liver?
Using Regat (Kopran Ltd) does not have any harmful effects on the liver.
What is the effect of Regat (Kopran Ltd) on the Heart?
Regat (Kopran Ltd) is completely safe for the heart.
Regat (Kopran Ltd) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Regat (Kopran Ltd) unless your doctor advises you to do so -
Is this Regat (Kopran Ltd) habit forming or addictive?
No, there is no any evidence that Regat (Kopran Ltd) is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Regat (Kopran Ltd) since it will not make you feel sleepy.
Is it safe?
No, Regat (Kopran Ltd) is not completely safe.
Is it able to treat mental disorders?
There is no benefit of taking Regat (Kopran Ltd) for mental disorders.
Interaction between Food and Regat (Kopran Ltd)
Regat (Kopran Ltd) may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Regat (Kopran Ltd)
No research has been done on this till date. Therefore, it is not known what the effect of taking Regat (Kopran Ltd) with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; ZymaxidY™ (gatifloxacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 714
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1399